Teva Pharmaceutical Industries Limited (VIE:TEVA)

Austria flag Austria · Delayed Price · Currency is EUR
24.20
+0.60 (2.54%)
At close: Dec 4, 2025
46.67%
Market Cap 28.07B
Revenue (ttm) 14.30B
Net Income (ttm) 607.69M
Shares Out n/a
EPS (ttm) 0.53
PE Ratio 46.19
Forward PE 10.83
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 114
Open 23.90
Previous Close 23.60
Day's Range 23.80 - 24.20
52-Week Range 11.30 - 24.40
Beta n/a
RSI 78.24
Earnings Date Jan 28, 2026

About VIE:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com... [Read more]

Industry Pharmaceutical Preparations
Founded 1901
Employees 35,686
Stock Exchange Vienna Stock Exchange
Ticker Symbol TEVA
Full Company Profile

Financial Performance

In 2024, VIE:TEVA's revenue was $16.54 billion, an increase of 4.40% compared to the previous year's $15.85 billion. Losses were -$1.64 billion, 193.2% more than in 2023.

Financial numbers in USD Financial Statements

News

There is no news available yet.